Nikia Laurie to Cell Line, Tumor
This is a "connection" page, showing publications Nikia Laurie has written about Cell Line, Tumor.
Connection Strength
0.331
-
Montoya V, Fan H, Bryar PJ, Weinstein JL, Mets MB, Feng G, Martin J, Martin A, Jiang H, Laurie NA. Novel miRNA-31 and miRNA-200a-Mediated Regulation of Retinoblastoma Proliferation. PLoS One. 2015; 10(9):e0138366.
Score: 0.086
-
Martin A, Jones A, Bryar PJ, Mets M, Weinstein J, Zhang G, Laurie NA. MicroRNAs-449a and -449b exhibit tumor suppressive effects in retinoblastoma. Biochem Biophys Res Commun. 2013 Nov 01; 440(4):599-603.
Score: 0.075
-
Martin J, Bryar P, Mets M, Weinstein J, Jones A, Martin A, Vanin EF, Scholtens D, Costa FF, Soares MB, Laurie NA. Differentially expressed miRNAs in retinoblastoma. Gene. 2013 Jan 10; 512(2):294-9.
Score: 0.070
-
Laurie NA, Comegys MM, Carreiro MP, Brown JF, Flanagan DL, Brilliant KE, Hixson DC. Carcinoembryonic antigen-related cell adhesion molecule 1a-4L suppression of rat hepatocellular carcinomas. Cancer Res. 2005 Dec 01; 65(23):11010-7.
Score: 0.043
-
Laurie NA, Gray JK, Zhang J, Leggas M, Relling M, Egorin M, Stewart C, Dyer MA. Topotecan combination chemotherapy in two new rodent models of retinoblastoma. Clin Cancer Res. 2005 Oct 15; 11(20):7569-78.
Score: 0.043
-
Shih CS, Laurie N, Holzmacher J, Spence Y, Nathwani AC, Davidoff AM, Dyer MA. AAV-mediated local delivery of interferon-beta for the treatment of retinoblastoma in preclinical models. Neuromolecular Med. 2009; 11(1):43-52.
Score: 0.014